Hereditary Nonpolyposis Colorectal Cancer
Links shared publicly online about this topic
Hereditary Colorectal Cancer: eMedicine Gastroenterology
emedicine.medscape.com — “Overview: INTRODUCTION Hereditary nonpolyposis colorectal cancer (HNPCC), an autosomal-dominant syndrome, accounts for 2-5% of all colorectal carcinomas. Colorectal cancer in patients with hereditary nonpolyposis colorectal cancer (HNPCC) presents at an earlier age than in the general population and ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 11, 2010 at 3:34 pm By:
Susan Scroggins Health Advocate and Active Health Library
Hereditary nonpolyposis colorectal cancer accounts for 2-5% of all colorectal carcinomas. Learn more. http://bit.ly/9laadK
Oncology Article | Alcohol Drinking Colorectal Neoplasms History Smoking Colorectal Neoplasms, Hereditary Nonpolyposis Survival
mdlinx.com — “Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival” View full resource at mdlinx.com
Most Recently Shared on April 20, 2011 at 12:10 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: Cancer http://bit.ly/fmn3Ni #oncology
Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer -- Hitchins and Ward 46 (12): 793 -- Journal of Medical Genetics
jmg.bmj.com — “Hitchins, M P; Ward, R L” View full resource at jmg.bmj.com
Most Recently Shared on December 2, 2009 at 2:53 am By:
Mark Robson Oncologist, Hematologist, Physician, Doctor, and Internist
Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer http://bit.ly/4CKtz2
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial : The Lancet
thelancet.com — “Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. By - Prof Sir John Burn MD, Prof Anne-Marie Gerdes MD...” View full resource at thelancet.com
Most Recently Shared on October 31, 2011 at 7:39 pm By:
Alvin B. Lin Doctor, Family Medicine Doctor, Geriatrician, and Physician
Check out #Lancet study http://t.co/X0cPiZZF re #aspirin to prevent #colon #colorectal #cancer in high risk pts. http://t.co/zDTDN6Nh
Aspirin reduces colorectal cancer rates by around 60% in those with increased hereditary risk http://t.co/rgHjCoUE
download.thelancet.com — “Aspirin reduces colorectal cancer rates by around 60% in those with increased hereditary risk http://t.co/rgHjCoUE” View full resource at download.thelancet.com
Most Recently Shared on October 28, 2011 at 1:32 pm By:
Aspirin reduces colorectal cancer rates by around 60% in those with increased hereditary risk http://t.co/rgHjCoUE
Video: DNA discovery opens new door to develop therapies for hereditary cancers
labspaces.net — “By solving the three-dimensional structure of a protein involved in repairing DNA errors, a group of McMaster University researchers have revealed new avenues to develop assessment tools and alternative treatments for people living with hereditary colorectal cancers.” View full resource at labspaces.net
Most Recently Shared on July 8, 2010 at 4:58 pm By:
Video: DNA discovery opens new door to develop therapies for hereditary cancers - http://is.gd/dkeli
VICC seeks to halt colorectal cancer?s impact on family (09/29/11)
mc.vanderbilt.edu — “As program coordinator for the Vanderbilt Hereditary Colorectal Cancer Registry, Duveen Sturgeon, R.N., regularly meets with patients and their families in the hospital to discuss the importance of being tested for the disease, which can be carried genetically to other family members.” View full resource at mc.vanderbilt.edu
Most Recently Shared on September 30, 2011 at 5:34 pm By:
Cynthia Floyd Manley Health Executive
I've known Duveen for 5 years. This house call to break family cycle of colorectal cancer is typical of her dedication! http://ow.ly/6JQWe
Lynch syndrome: Identifying patients at risk for HNPCC - ONA
oncologynurseadvisor.com — “Hereditary nonpolyposis colorectal cancer is caused by an inherited genetic mutation. This review explains how to screen and counsel patients at risk.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 16, 2011 at 2:35 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Lynch syndrome: Identifying patients at risk for HNPCC http://goo.gl/fb/n3PgR
Aspirin associated with colorectal cancer prevention in Lynch syndrome | HemOncToday
hemonctoday.com — “Administering two aspirin per day to patients with hereditary bowel cancer reduced their risk for colorectal cancer by more than half within 5” View full resource at hemonctoday.com
Most Recently Shared on October 28, 2011 at 3:07 pm By:
HemOnc Today Oncology and Health News
#Aspirin associated with colorectal #cancer prevention in Lynch syndrome http://t.co/9whrwFx7
DNA Discovery Opens New Door To Develop Tools, Therapies For Hereditary Cancers
medicalnewstoday.com — “By solving the three-dimensional structure of a protein involved in repairing DNA errors, a group of McMaster University researchers have revealed new avenues to develop assessment tools and alter” View full resource at medicalnewstoday.com
Most Recently Shared on July 9, 2010 at 3:06 pm By:
DNA Discovery Opens New Door To Develop Tools, Therapies For Hereditary Cancers http://mnt.to/3FSG #biology
New test targets Lynch syndrome, a risk factor for colon cancer
sciencedaily.com — “Researchers have developed a screening procedure that could dramatically increase testing for Lynch syndrome, a hereditary genetic disorder that raises cancer risk, particularly for colorectal cancer.” View full resource at sciencedaily.com
Most Recently Shared on June 2, 2011 at 3:49 pm By:
New test targets Lynch syndrome, a risk factor for colon cancer http://bit.ly/iHVQim
Test Targets Lynch Syndrome, a Risk Factor for Colon Cancer
newswise.com — “Mayo Clinic has developed a screening procedure that could dramatically increase testing for Lynch syndrome, a hereditary genetic disorder that raises cancer risk, particularly for colorectal cancer.” View full resource at newswise.com
Most Recently Shared on May 18, 2011 at 3:57 pm By:
Test Targets Lynch Syndrome, a Risk Factor for Colon Cancer: Mayo Clinic has developed a screening proce... http://bit.ly/j9pR87 #cancer
Test Targets Lynch Syndrome, a Risk Factor for Colon Cancer
newswise.com — “Mayo Clinic has developed a screening procedure that could dramatically increase testing for Lynch syndrome, a hereditary genetic disorder that raises cancer risk, particularly for colorectal cancer.” View full resource at newswise.com
Most Recently Shared on May 18, 2011 at 4:36 pm By:
#health news: Test Targets Lynch Syndrome, a Risk Factor for Colon Cancer: Mayo Clinic has developed a screening... http://bit.ly/jgroGa
Brupbacher Prize goes to B. Vogelstein and J. Hoeijmakers for research on colorectal and skin cancer
eurekalert.org — “Today, the Charles Rodolphe Brupbacher Prize for Cancer Research 2011 goes to two researchers who have contributed to better understanding of the genetics underlying the growth of tumors. Oncologist Bert Vogelstein has demonstrated how sequential accumulation of mutations leads to colorectal cancer, and Jan H. Hoeijmakers has conducted breakthrough research in xeroderma, a hereditary disease causing skin cancer.” View full resource at eurekalert.org
Most Recently Shared on February 17, 2011 at 7:24 pm By:
Brupbacher Prize goes to B. Vogelstein and J. Hoeijmakers for research on colorectal and skin cancer: ( Universi... http://bit.ly/dN7Rrx
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Susan Scroggins
Passionate about sharing quality health resources for good health. Content curator and organizer at organizedwisdom.com.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Mark Robson
medical oncologist concentrating on clinical translation of germline genetics; opinions expressed here are my own, not my employer's
Advertisement
